Taken together, our findings of lower baseline adiponectin levels in progressors to prediabetes versus nonprogressors, an inverse correlation between adiponectin and BMD, and a positive association between BMD and incident prediabetes, implicate adiponectin as a possible mediator of the link between BMD and prediabetes risk. Here, ADIPOQ is linked to prediabetes syndrome.